104 related articles for article (PubMed ID: 35343664)
1. Role of demographics in noninvasive testing for colorectal cancer screening: do targeted cut-off values improve detection?
Gill I; Shams C; Hanna A; George J; Jamil LH; Patel A
Minerva Gastroenterol (Torino); 2023 Dec; 69(4):459-469. PubMed ID: 35343664
[TBL] [Abstract][Full Text] [Related]
2. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.
Nielson CM; Petrik AF; Jacob L; Vollmer WM; Keast EM; Schneider JL; Rivelli JS; Kapka TJ; Meenan RT; Mummadi RR; Green BB; Coronado GD
Cancer Med; 2018 Sep; 7(9):4781-4790. PubMed ID: 30101513
[TBL] [Abstract][Full Text] [Related]
3. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
[TBL] [Abstract][Full Text] [Related]
4. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
5. False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use.
Domper Arnal MJ; García Mateo S; Hermoso-Durán S; Abad D; Carrera-Lasfuentes P; Velazquez-Campoy A; Abian Franco O; Lanas A
Int J Colorectal Dis; 2021 Sep; 36(9):1861-1869. PubMed ID: 33982138
[TBL] [Abstract][Full Text] [Related]
6. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
7. The effect of numeric information about the likelihood of receiving a false negative or false positive result on people's attitudes towards colorectal cancer screening using faecal immunochemical testing (FIT).
Miles A; Paschalidi A; Sharma N
Patient Educ Couns; 2023 Sep; 114():107857. PubMed ID: 37348310
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
9. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
11. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
Ibáñez-Sanz G; Milà N; de la Peña-Negro LC; Garcia M; Vidal C; Rodríguez-Alonso L; Binefa G; Rodríguez-Moranta F; Moreno V
J Gastroenterol; 2021 Jan; 56(1):42-53. PubMed ID: 33159805
[TBL] [Abstract][Full Text] [Related]
13. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
Petersen MM; Kleif J; Jørgensen LN; Hendel JW; Seidelin JB; Madsen MR; Vilandt J; Brandsborg S; Rasmussen JS; Andersen LM; Khalid A; Ferm L; Gawel SH; Martens F; Andersen B; Rasmussen M; Davis GJ; Christensen IJ; Therkildsen C
Clin Colorectal Cancer; 2023 Jun; 22(2):199-210. PubMed ID: 36878807
[TBL] [Abstract][Full Text] [Related]
15. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.
Ibañez-Sanz G; Garcia M; Milà N; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Benito L; Padrol I; Barenys M; Moreno V
Eur J Cancer Prev; 2017 Sep; 26(5):365-367. PubMed ID: 27433880
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
17. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
18. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
19. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
van Turenhout ST; Oort FA; van der Hulst RW; Visscher AP; Terhaar sive Droste JS; Scholten P; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG; Coupé VM
BMC Gastroenterol; 2014 Dec; 14():217. PubMed ID: 25528043
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
